Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd D Armstrong

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|August 4, 2004
Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patientsAmy Morck Thomas, Lynn M Santarsiero, Eric R Lutz, et al.
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
The Journal of Experimental Medicine|May 11, 2005
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune responseAnne M Ercolini, Brian H Ladle, Elizabeth A Manning, et al.
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigenSatoshi Murata, Brian H Ladle, Peter S Kim, et al.
The Journal of Clinical Investigation|April 10, 2008
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCsPeter S Kim, Todd D Armstrong, Hong Song, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodiesVictoria M Kim, Alex B Blair, Peter Lauer, et al.
Cancer Immunology Research|October 21, 2018
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCsBrian J Christmas, Christine I Rafie, Alexander C Hopkins, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic CancerAlex B Blair, Victoria M Kim, Stephen T Muth, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|August 4, 2004
Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patientsAmy Morck Thomas, Lynn M Santarsiero, Eric R Lutz, et al.
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
The Journal of Experimental Medicine|May 11, 2005
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune responseAnne M Ercolini, Brian H Ladle, Elizabeth A Manning, et al.
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigenSatoshi Murata, Brian H Ladle, Peter S Kim, et al.
The Journal of Clinical Investigation|April 10, 2008
Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCsPeter S Kim, Todd D Armstrong, Hong Song, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodiesVictoria M Kim, Alex B Blair, Peter Lauer, et al.
Cancer Immunology Research|October 21, 2018
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCsBrian J Christmas, Christine I Rafie, Alexander C Hopkins, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2019
Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic CancerAlex B Blair, Victoria M Kim, Stephen T Muth, et al.
Pageof 5